SCHEMBL13454737

SCHEMBL13454737

CCOc1ccc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)c3ccc(Cl)cc3Cl)cc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PCTP Q9UKL6 3/20 0.69
▸ ALDH1A1 P00352 6/20 0.67
▸ MEN1 O00255 5/20 0.67
▸ KMT2A Q03164 5/20 0.67
▸ ALOX12 P18054 3/20 0.64
▸ GAA P10253 2/20 0.64
▸ HPGD P15428 2/20 0.64
▸ NPSR1 Q6W5P4 3/20 0.63
▸ MAPT P10636 3/20 0.63
▸ POLB P06746 2/20 0.63
▸ LMNA P02545 2/20 0.63
▸ CA1 P00915 1/20 0.62
▸ CA2 P00918 1/20 0.62
▸ CA9 Q16790 1/20 0.62
▸ HTT P42858 1/20 0.61
▸ GPR27 Q9NS67 3/20 0.58
▸ AVPR2 P30518 2/20 0.58
▸ STARD7 Q9NQZ5 1/20 0.55
▸ STARD10 Q9Y365 1/20 0.55
▸ PPIA P62937 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13454736 0.89 PCTP (0.69) PCTPALDH1A1MEN1KMT2AALOX12
SCHEMBL13454712 0.89 ALDH1A1 (0.69) PCTPALDH1A1MEN1KMT2AALOX12
SCHEMBL13454706 0.86 ALDH1A1 (0.72) ALDH1A1MEN1KMT2AALOX12GAA
SCHEMBL13453906 0.85 ALDH1A1 (0.70) ALDH1A1MEN1KMT2AALOX12GAA
SCHEMBL17066583 0.85 GPR27 (0.79) PCTPMEN1KMT2AALOX12GAA
SCHEMBL13454554 0.85 ALDH1A1 (0.67) ALDH1A1MEN1KMT2AALOX12GAA
SCHEMBL13454738 0.83 PCTP (0.81) PCTPALDH1A1MEN1KMT2AALOX12
SCHEMBL13469775 0.83 ALDH1A1 (0.79) ALDH1A1MEN1KMT2AALOX12GAA
SCHEMBL13454618 0.82 PCTP (0.74) PCTPALDH1A1MEN1KMT2AALOX12
SCHEMBL17066548 0.82 KMT2A (0.70) ALDH1A1MEN1KMT2AALOX12GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9126938-B2 Phosphatidylcholine transfer protein inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2015-09-08 — — US disclosed
US-9126938-B2 Phosphatidylcholine transfer protein inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2015-09-08 — — US disclosed
US-20120264756-A1 Phosphatidylcholine Transfer Protein Inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2012-10-18 — — US disclosed
US-20120264756-A1 Phosphatidylcholine Transfer Protein Inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2012-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264756-A1 Phosphatidylcholine Transfer Protein Inhibitors PCTP, LCAT, CETP PCTP 1/4885ALDH1A1 4289/4885MEN1 1940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback